Reaction Details Report a problem with these data
Target
Monoglyceride lipase
Ligand
BDBM483674
Substrate
n/a
Meas. Tech.
In Vitro Competitive Activity-Based Protein Profiling
IC50
<100±n/a nM
Citation
 Grice, CA; Wiener, JJ; Weber, OD; Duncan, KK Pyrazole MAGL inhibitors US Patent  US10927105 Publication Date 2/23/2021 
Target
Name:
Monoglyceride lipase
Synonyms:
HU-K5 | Lysophospholipase homolog | Lysophospholipase-like | MAGL | MGL | MGLL | MGLL_HUMAN
Type:
Hydrolase
Mol. Mass.:
33264.56
Organism:
Homo sapiens (Human)
Description:
Human recombinant MGL (Cayman Chemical, cat# 10008354).
Residue:
303
Sequence:
MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP
  
Inhibitor
Name:
BDBM483674
Synonyms:
(S)-1-(4-(2-(3- fluoropyrrolidin-1- yl)-4-(trifluoromethyl)- benzyl)-piperazine-1- carbonyl)-1H- pyrazole-3- carboxylic acid | US10927105, Ex 92 | US11655217, Example 92
Type:
Small organic molecule
Emp. Form.:
C21H23F4N5O3
Mol. Mass.:
469.4326
SMILES:
OC(=O)c1ccn(n1)C(=O)N1CCN(Cc2ccc(cc2N2CC[C@H](F)C2)C(F)(F)F)CC1 |r|
Structure:
Search PDB for entries with ligand similarity: